Clinical Trial: A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07652723) titled 'A Study to Learn About How Safe BAY3389934 is and How it Affects Blood Clotting When Given Alone or With Aspirin in Healthy Participants' on June 08.

Brief Summary: The study treatment BAY3389934 is under development for people with blood clotting problems that occur due to sepsis.

Sepsis is a serious condition that happens when the body's reaction to an infection causes organ damage. It can eventually lead to tiny blood clots formation throughout the body.

BAY3389934 aims to work by blocking two important blood clotting proteins, called Factor IIa (thrombin) and Factor Xa, both of which help in blood clotting. By blocking them, B...